Insider filing · NBIX
Leslie V Norwalk
Director
profile →
Neurocrine Biosciences, Inc.
NBIX · Healthcare · 59 filings in 24 months
ticker →
Leslie V Norwalk sold $946K of Neurocrine Biosciences (NBIX)
Executed Dec 15 2025, disclosed Dec 17 2025, 2 days later.
Value, as filed
$946K
6,190 sh across 2 lots
Executed
Dec 15 2025
the trade date, as filed
Disclosed
Dec 17 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
LNLeslie V Norwalk (Director) filed 6 Form 4 reports in the trailing twelve months (0 purchases, 6 sales), most often in Neurocrine Biosciences, Inc. (NBIX). The largest single filing was $946K of NBIX (6,190 sh across 2 lots, as filed), executed Dec 15 2025.
The name
NBIXHealthcare · Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunolog…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Leslie V Norwalk in NBIX
NBIXSALE
Neurocrine Biosciences, Inc.
$228K1,250 sh × $182.01
Exec Jul 28
Filed Jul 30 · 5:29 PM ET NBIXSALE Neurocrine Biosciences, Inc. $210K
1,250 sh × $168.06
Exec Jun 4
Filed Jun 8 · 5:30 PM ET NBIXSALE Neurocrine Biosciences, Inc. $591K
3,810 sh × $155.01
Exec May 12
Filed May 14 · 5:30 PM ET